Why Is Leqvio So Hard to Find? [Explained for 2026]

If you've been prescribed Leqvio (inclisiran) and gone looking for it at your local pharmacy, you've probably run into a wall. It's not on the shelves. Your pharmacist may not even have it. And your insurance company seems to have a long checklist before they'll approve it. So what's going on?

The answer isn't a shortage in the traditional sense. Leqvio is simply a different kind of medication, and it moves through the healthcare system in a completely different way than your typical prescription drug. Understanding why can save you a lot of frustration.

What Makes Leqvio Different From Most Prescriptions?

Leqvio is a first-in-class small interfering RNA (siRNA) therapy made by Novartis. It was FDA-approved on December 22, 2021, to lower LDL cholesterol ("bad" cholesterol) in adults with high cholesterol, including those with heterozygous familial hypercholesterolemia (HeFH) or atherosclerotic cardiovascular disease (ASCVD).

Here's the key difference: Leqvio is not a take-home prescription. It is a subcutaneous injection that must be administered by a healthcare provider in a clinical setting — a doctor's office, cardiology clinic, or infusion center. You cannot pick it up at Walgreens or CVS and inject it yourself at home.

This is called a "buy-and-bill" or "physician-administered" medication. Your doctor's office orders the drug directly, stores it, and bills your insurance under the medical benefit (not the pharmacy benefit) when they administer it.

Why Can't I Just Pick It Up at a Pharmacy?

Leqvio's delivery model is by design. The drug is given as a 284 mg subcutaneous injection into the abdomen, upper arm, or thigh. The dosing schedule is: one injection initially, another at 3 months, then every 6 months after that. Because the injection requires clinical oversight and proper technique, Novartis and the FDA determined it should only be administered by a trained healthcare provider.

This means the drug sits in your doctor's supply cabinet, not a pharmacy shelf. It's billed under your medical benefit — think of it more like getting a flu shot or a Botox injection at a doctor's office than picking up a bottle of blood pressure pills.

Is There a Leqvio Shortage in 2026?

As of 2026, Leqvio is not on any FDA drug shortage list. The drug is manufactured by Novartis and has been commercially available in the U.S. since its approval in late 2021. Supply is generally stable.

However, patients may still face hurdles finding it for these reasons:

• Not all clinics stock it — your doctor's office needs to set up a procurement relationship with a specialty distributor or Novartis directly.
• Prior authorization is required by most insurance plans before the injection can be covered.
• Step therapy requirements may apply — some insurers require a documented trial of statins or other cholesterol medications first.
• Patients referred to a new specialist may need to wait for the provider to arrange sourcing.

Why Does Insurance Make Leqvio So Hard to Get?

Leqvio has a list price of approximately $3,652–$3,731 per injection. For the first year, a patient needs three doses (month 0, month 3, month 9), making the first-year cost roughly $9,750. After that, it's two doses per year, or about $6,500 annually.

Because of this price, most commercial insurers, including Cigna, UnitedHealthcare, and Aetna, require prior authorization. They typically want to see:

1. Documented diagnosis of HeFH or ASCVD
2. Evidence of current or maximally tolerated statin therapy (or documented statin intolerance)
3. LDL-C level at or above a threshold (often 70 mg/dL or higher)
4. Prior trial of ezetimibe in some cases

Once prior authorization is approved, the good news is that coverage is usually very favorable. According to Novartis, 92% of patients with commercial insurance have confirmed medical benefit coverage, and 75% pay less than $10 per treatment.

What If My Doctor Doesn't Have Leqvio in Their Office?

This is one of the most common barriers. Not every primary care office or even every cardiology practice has Leqvio stocked. If your doctor has prescribed it but can't administer it, here are your next steps:

• Ask your doctor for a referral to a cardiologist or lipid specialist who regularly administers Leqvio.
• Contact the Leqvio Service Center at 1-833-537-8462 — they can help connect you with providers in your area who administer it.
• Ask if a nearby infusion center or hospital clinic can administer it.

How medfinder Can Help You Find Leqvio

Finding the right clinic that stocks Leqvio and can schedule your injection promptly isn't always easy. That's where medfinder comes in. medfinder calls clinics and pharmacies on your behalf to find out which ones have your medication available and can schedule your appointment — texting you the results directly.

Instead of calling clinic after clinic yourself, you can let medfinder do the legwork. This is especially useful for specialty injectables like Leqvio, where availability varies by provider.

What About Cost If You Don't Have Insurance?

If you're uninsured or underinsured, Novartis offers the Novartis Patient Assistance Foundation (www.pap.novartis.com), which may provide Leqvio at no charge for eligible patients. You can also contact the Leqvio Service Center for additional affordability support options.

For patients with commercial insurance, the Leqvio Co-Pay Program can bring costs down to $0. Note: this program is not valid for Medicare or Medicaid.

The Bottom Line

Leqvio isn't hard to find because of a supply shortage — it's hard to find because it's a physician-administered specialty drug that works differently from typical prescriptions. The barriers are logistical (finding the right clinic) and administrative (prior authorization). Read our guide on how to find Leqvio near you for step-by-step tips.

Want to know what to expect from the injection itself? Check out our guide to Leqvio side effects and what to tell your doctor.